Altered development of intestinal intraepithelial lymphocytes in P-glycoprotein-deficient mice

Developmental and Comparative Immunology

Volumn 24, Issue 8, 2000, Pages 783-795

  Eisenbraun, Michael D ^a   Mosley, R Lee ^a   Teitelbaum, Daniel H ^b   Miller, Richard A ^a,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b CS Mott's C   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Alpha beta TCR; CD8; Gamma delta TCR; Knockout mice; Mucosa; Repertoire development; T lymphocytes

Indexed keywords

CD8 ANTIGEN; GAMMA INTERFERON; GLYCOPROTEIN P; INTERLEUKIN 2; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DEVELOPMENT; INTESTINE EPITHELIUM; INTESTINE EPITHELIUM CELL; KNOCKOUT MOUSE; MALE; MOUSE; MUCOSA; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0033920539     PISSN: 0145305X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-305X(00)00029-X     Document Type: Article

References (49)

1. Beagley K.W, Husband A.J. Intraepithelial lymphocytes: origins, distribution, and function. Crit. Rev. Immunol. 18:(3):1998;237-254.
2. Klein J.R., Mosley R.L. Phenotypic and cytotoxic characteristics of intraepithelial lymphocytes. Kiyono H, McGhee J.R. Mucosal immunology: intraepithelial lymphocytes. 1993;Raven Press, New York.
3. Higgins C.F. ABC transporters: from micro-organisms to man. Annu. Rev. Cell Biol. 8:1992;67-113.
4. Bommhardt U., Cerottini J.C., MacDonald H.R. Heterogeneity in P-glycoprotein (multidrug resistance) activity among murine peripheral T cells: correlation with surface phenotype and effector function. Eur. J. Immunol. 24:(12):1994;2974-2981.
5. Witkowski J.M., Li S.P., Gorgas G., Miller R.A. Extrusion of the P-glycoprotein substrate rhodamine-123 distinguishes CD4 memory T cell subsets that differ in IL-2- driven IL-4 production. J. Immunol. 153:(2):1994;658-665.
6. Panwala C.M., Jones J.C., Viney J.L. A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis. J. Immunol. 161:(10):1998;5733-5744.
7. Goldstein L.J., Galski H., Fojo A., Willingham M., Lai S.L., Gazdar A., Pirker R., Green A., Crist W., Brodeur G.M. Expression of a multidrug resistance gene in human cancers. J. Natl. Cancer Inst. 81:(2):1989;116-124.
8. Thiebaut F., Tsuruo T., Hamada H., Gottesman M.M., Pastan I., Willingham M.C. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc. Natl. Acad. Sci. USA. 84:(21):1987;7735-7738.
9. Croop J.M., Raymond M., Haber D., Devault A., Arceci R.J., Gros P., Housman D.E. The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues. Mol. Cell Biol. 9:(3):1989;1346-1350.
10. Hsing S., Gatmaitan Z., Arias I.M. The function of Gp170, the multidrug-resistance gene product, in the brush border of rat intestinal mucosa. Gastroenterology. 102:(3):1992;879-885.
11. Borst P., Schinkel A.H. Genetic dissection of the function of mammalian P-glycoproteins. Trends Genet. 13:(6):1997;217-222.
12. Smit J.J., Schinkel A.H., Oude Elferink R.P., Groen A.K., Wagenaar E., van Deemter L., Mol C.A., Ottenhoff R, van der Lugt NM, van Roon M.A. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell. 75:(3):1993;451-462.
13. Crawford A.R., Smith A.J., Hatch V.C., Oude Elferink R.P., Borst P., Crawford J.M. Hepatic secretion of phospholipid vesicles in the mouse critically depends on mdr2 or MDR3 P-glycoprotein expression. Visualization by electron microscopy. J. Clin. Invest. 100:(10):1997;2562-2567.
14. Neyfakh A.A., Serpinskaya A.S., Chervonsky A.V., Apasov S.G., Kazarov A.R. Multidrug-resistance phenotype of a subpopulation of T-lymphocytes without drug selection. Exp. Cell Res. 185:(2):1989;496-505.
15. Eisenbraun M.D., Miller R.A. mdr1a-encoded P-glycoprotein is not required for peripheral T cell proliferation, cytokine release, or cytotoxic effector function in mice. J. Immunol. 163:(5):1999;2621-2627.
16. Gupta S., Kim C.H., Tsuruo T., Gollapudi S. Preferential expression and activity of multidrug resistance gene 1 product (P-glycoprotein), a functionally active efflux pump, in human CD8+ T cells: a role in cytotoxic effector function. J. Clin. Invest. 12:(6):1992;451-458.
17. Drach J., Gsur A., Hamilton G., Zhao S., Angerler J., Fiegl M., Zojer N., Raderer M., Haberl I., Andreeff M., Huber H. Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-gamma in normal human T lymphocytes. Blood. 88:(5):1996;1747-1754.
18. Raghu G., Park S.W., Roninson I.B., Mechetner E.B. Monoclonal antibodies against P-glycoprotein, an MDR1 gene product, inhibit interleukin-2 release from PHA-activated lymphocytes. Exp. Hematol. 24:(10):1996;1258-1264.
19. Mosley R.L., Klein J.R. A rapid method for isolating murine intestine intraepithelial lymphocytes with high yield and purity. J. Immunol. Methods. 156:(1):1992;19-26.
20. Witkowski J.M., Miller R.A. Increased function of P-glycoprotein in T lymphocyte subsets of aging mice. J. Immunol. 150:(4):1993;1296-1306.
21. Neyfakh A.A., Dmitrevskaya T.V., Serpinskaya A.S. The membrane transport system responsible for multidrug resistance is operating in non-resistant cells. Exp. Cell Res. 178:(2):1988;513-517.
22. Chaudhary P.M., Mechetner E.B., Roninson I.B. Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes. Blood. 80:(11):1992;2735-2739.
23. Twentyman P.R., Rhodes T., Rayner S. A comparison of rhodamine-123 accumulation and efflux in cells with P- glycoprotein-mediated and MRP-associated multidrug resistance phenotypes. Eur. J. Cancer. 30A:(9):1994;1360-1369.
24. Sydora B.C., Mixter P.F., Holcombe H.R., Eghtesady P., Williams K., Amaral M.C., Nel A., Kronenberg M. Intestinal intraepithelial lymphocytes are activated and cytolytic but do not proliferate as well as other T cells in response to mitogenic signals. J. Immunol. 150:(6):1993;2179-2191.
25. Mosley R.L., Whetsell M., Klein J.R. Proliferative properties of murine intestinal intraepithelial lymphocytes (IEL): IEL expressing TCR alpha beta or TCR tau delta are largely unresponsive to proliferative signals mediated via conventional stimulation of the CD3-TCR complex. Int. Immunol. 3:(6):1991;563-569.
26. Pilarski L.M., Paine D., McElhaney J.E., Cass C.E., Belch A.R. Multidrug transporter P-glycoprotein 170 as a differentiation antigen on normal human lymphocytes and thymocytes: modulation with differentiation stage and during aging. Am. J. Hematol. 49:(4):1995;323-335.
27. Lucia M.B., Cauda R., Landay A.L., Malorni W., Donelli G., Ortona L. Transmembrane P-glycoprotein (P-gp/P-170) in HIV infection: analysis of lymphocyte surface expression and drug-unrelated function. AIDS Res. Hum. Retrov. 11:(8):1995;893-901.
28. Linton P.J., Haynes L., Klinman N.R., Swain S.L. Antigen-independent changes in naive CD4 T cells with aging. J. Exp. Med. 184:(5):1996;1891-1900.
29. Raghu G., Pierre-Jerome M., Dordal M.S., Simonian P., Bauer K.D., Winter J.N. P-glycoprotein and alterations in the glutathione/glutathione-peroxidase cycle underlie doxorubicin resistance in HL-60-R, a subclone of the HL-60 human leukemia cell line. Int. J. Cancer. 53:(5):1993;804-811.
30. Schuetz E.G., Beck W.T., Schuetz J.D. Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells. Mol. Pharmacol. 49:(2):1996;311-318.
31. Schinkel A.H., Smit J.J., van Tellingen O., Beijnen J.H., Wagenaar E., van Deemter L., Mol C.A., van der Valk M.A., Robanus-Maandag E.C., te Riele H.P. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell. 77:(4):1994;491-502.
32. Smit J.W., Schinkel A.H., Muller M., Weert B., Meijer D.K. Contribution of the murine mdr1a P-glycoprotein to hepatobiliary and intestinal elimination of cationic drugs as measured in mice with an mdr1a gene disruption. Hepatology. 27:(4):1998;1056-1063.
33. Lown K.S., Mayo R.R., Leichtman A.B., Hsiao H.L., Turgeon D.K., Schmiedlin-Ren P., Brown M.B., Guo W., Rossi S.J., Benet L.Z., Watkins P.B. Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine. Clin. Pharmacol. Ther. 62:(3):1997;248-260.
34. van Helvoort A., Smith A.J., Sprong H., Fritzsche I., Schinkel A.H., Borst P., van Meer G. MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell. 87:(3):1996;507-517.
35. Ueda K., Okamura N., Hirai M., Tanigawara Y., Saeki T., Kioka N., Komano T., Hori R. Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone. J. Biol. Chem. 267:(34):1992;24248-24252.
36. Valverde M.A., Diaz M., Sepulveda F.V., Gill D.R., Hyde S.C., Higgins C.F. Volume-regulated chloride channels associated with the human multidrug-resistance P-glycoprotein. Nature. 355:(6363):1992;830-833.
37. Devault A., Gros P. Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities. Mol. Cell Biol. 10:(4):1990;1652-1663.
38. Tang-Wai D.F., Kajiji S., DiCapua F., de Graaf D., Roninson I.B., Gros P. Human (MDR1) and mouse (mdr1, mdr3) P-glycoproteins can be distinguished by their respective drug resistance profiles and sensitivity to modulators. Biochemistry. 34:(1):1995;32-39.
39. Beagley K.W., Fujihashi K., Lagoo A.S., Lagoo-Deenadaylan S., Black C.A., Murray A.M., Sharmanov A.T., Yamamoto M., McGhee J.R., Elson C.O., et al. Differences in intraepithelial lymphocyte T cell subsets isolated from murine small versus large intestine. J. Immunol. 154:(11):1995;5611-5619.
40. Camerini V., Panwala C., Kronenberg M. Regional specialization of the mucosal immune system. Intraepithelial lymphocytes of the large intestine have a different phenotype and function than those of the small intestine. J. Immunol. 151:(4):1993;1765-1776.
41. Itohara S., Mombaerts P., Lafaille J., Iacomini J., Nelson, Clarke A.R., Hooper M.L., Farr A., Tonegawa S. T cell receptor delta gene mutant mice: independent generation of alpha beta T cells and programmed rearrangements of gamma delta TCR genes. Cell. 72:(3):1993;337-348.
42. Fung-Leung W.P., Kishihara K., Gray D., Teh H.S., Lau C.Y., Mak T.W. Intestinal T cells in CD8 alpha knockout mice and T cell receptor transgenic mice. Adv. Exp. Med. Biol. 371A:1995;121-124.
43. Hughes D.P., Hayday A., Craft J.E., Owen M.J., Crispe I.N. T cells with gamma/delta T cell receptors (TCR) of intestinal type are preferentially expanded in TCR-alpha-deficient lpr mice. J. Exp. Med. 182:(1):1995;233-241.
44. + intestinal intraepithelial T cells in beta 2-microglobulin- and/or TAP1-deficient mice. J. Immunol. 156:(8):1996;2710-2715.
45. Bining N., Miller R.A. Cytokine production by subsets of CD4 memory T cells differing in P-glycoprotein expression: effects of aging. J. Gerontol. A Biol. Sci. Med. Sci. 52:(3):1997;B137-B145.
46. Gramzinski R.A., Adams E., Gross J.A., Goodman T.G., Allison J.P., Lefrancois L. T cell receptor-triggered activation of intraepithelial lymphocytes in vitro. Int. Immunol. 5:(2):1993;145-153.
47. Ohteki T., MacDonald H.R. Expression of the CD28 costimulatory molecule on subsets of murine intestinal intraepithelial lymphocytes correlates with lineage and responsiveness. Eur. J. Immunol. 23:(6):1993;1251-1255.
48. Barrett T.A., Gajewski T.F., Danielpour D., Chang E.B., Beagley K.W., Bluestone J.A. Differential function of intestinal intraepithelial lymphocyte subsets. J. Immunol. 149:(4):1992;1124-1130.
49. Yamamoto M., Fujihashi K., Beagley K.W., McGhee J.R., Kiyono H. Cytokine synthesis by intestinal intraepithelial lymphocytes. Both gamma/delta T cell receptor-positive and alpha/beta T cell receptor-positive T cells in the G1 phase of cell cycle produce IFN-gamma and IL- 5. J. Immunol. 150:(1):1993;106-114.